COVID-19

Withdrawn applications

COVID-19 vaccines withdrawn from rolling review

Vaccine developers have withdrawn the following COVID-19 vaccines from the rolling review process:

VaccineVaccine developerKey milestonesMore information
CVnCoVCureVac AGRolling review started: 12/02/2021
 
Withdrawn from rolling review: 12/10/2021

COVID-19 vaccines withdrawn from marketing authorisation evaluation

Vaccine developers have withdrawn the following COVID-19 vaccines from the marketing authorisation evaluation process:

VaccineVaccine developerKey milestonesMore information
Skycovion SK Chemicals GmbHMarketing authorisation evaluation started: 18/08/2022
 
Withdrawn from marketing authorisation evaluation: 01/09/2023
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023

COVID-19 treatments withdrawn from marketing authorisation evaluation

Treatment developers have withdrawn the following COVID-19 treatments from the marketing authorisation evaluation process:

TreatmentTreatment developerKey milestonesMore information
Olumiant (baricitinib)Eli Lilly Nederland B.V.Marketing authorisation evaluation started: 23/11/2021

Withdrawn from marketing authorisation evaluation: 07/12/2022

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2022

 
Lagevrio (molnupiravir)Merck Sharp & Dohme and Ridgeback Biotherapeutics

Marketing authorisation evaluation started: 23/11/2021

CHMP negative opinion: 23/02/2023

Re-examination request submitted: 13/03/2023

Withdrawn from marketing authorisation evaluation: 21/06/2023

 

COVID-19 treatments withdrawn from rolling review

Treatment developers have withdrawn the following COVID-19 treatments from the rolling review process:

TreatmentTreatment developerKey milestonesMore information
Bamlanivimab and etesevimabEli LillyRolling review started: 11/03/2021

Withdrawn from rolling review: 29/10/2021
Latest news

Paediatric investigation plan for bamlanivimab

Paediatric investigation plan for etesevimab

How useful was this page?

Add your rating